You are here » Home » Companies » Aspira Pathlab & Diagnostics Ltd - Announcements

Aspira Pathlab & Diagnostics Ltd.

BSE: 540788 Sector: Health care
NSE: N.A. ISIN Code: INE500C01017
BSE 00:00 | 07 Oct 36.50 0






NSE 05:30 | 01 Jan Aspira Pathlab & Diagnostics Ltd

Announcement under Regulation 30 (LODR)-Preferential Issue

August 21, 2019, 4:21 pm | Source: BSE | Downlaod PDFDownload PDF

In relation to the proposed fund raising by preferential allotment of equity shares by the Aspira Pathlab & Diagnostics Limited (the Company). In furtherance to our letter dated July 31 2019 with respect to the issuance of Equity Shares on a preferential basis we wish to inform you that the board of directors of the Company (the Board) at its meeting held on August 21 2019 subject to the approval of the shareholders of the Company has approved the issue and allotment of up to 3800000 (Thirty Eight Lakhs) Equity Shares of face value of INR 10/- each at an issue price Rs. 26 (Rupees Twenty Six) including premium of Rs. 16 (Rupees Sixteen) to strategic investors not forming part of promoter or promoter group on a preferential basis on terms and conditions as approved by the Board.

We would also like to inform that an Annual General Meeting of the Members of the Company will be held on 21th September 2019 for seeking their approval for the above issue of shares.